Brief: China Regenerative Medicine International Posts Q1 Loss Attributable HK$53.4 Mln
May 11 (Reuters) - China Regenerative Medicine International
Ltd 8158.HK :
* Q1 LOSS ATTRIBUTABLE HK$53.4 MILLION VERSUS LOSS HK$54
MILLION
* Q1 REVENUE HK$25.4 MILLION VERSUS HK$138.9 MILLION
Source text for Eikon: ID:nHKSb4DC5y
Further company coverage: 8158.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital